Research study Program year 2022 Source: CMS Open Payments

Eva-25185-00 : Validation Study for A Gastroparesis Screening Tool

Research payments

$89,500

18 payments

Through program year 2022, $89,500 in research payments was reported against Eva-25185-00 : Validation Study for A Gastroparesis Screening Tool, across 18 payments, paid by Takeda Pharmaceuticals U.S.A., Inc..

Paid by: Takeda Pharmaceuticals U.S.A., Inc.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2022	Research	$60,000	13
2021	Research	$29,500	5

Breakdown

Who paid Research payments · program years 2021–2022

Takeda Pharmaceuticals U.S.A., Inc. $89,500 18 payments

Who received the money Research payments · program years 2021–2022

Conduct Clinical Trials Organisation paid for research $89,500 18 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

5 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.